Paclitaxel, uracil plus tegafur (UFT) and leucovorin (LV) in patients with pre-treated metastatic breast cancer: Preclinical rationale and phase I study results

被引：0
|
作者：
Passardi, A. [1 ]
Massa, I. [1 ]
Milandri, C. [1 ]
Cecconetto, L. [1 ]
Calpona, S. [1 ]
Ibrahim, T. [1 ]
Ridolfi, L. [1 ]
Zoli, W. [1 ]
Frassineti, L. [1 ]
Maltoni, R. [1 ]
机构：
[1] Ist Oncol Romagnolo, Forll, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI11 / XI12
页数：2
相关论文
共 50 条
  • [21] A dose finding followed by a phase II study of oral LIFT (uracil/tegafur) and lv (leucovorin) plus i.v. mitomycin (MMC) in patients (pts) with metastatic colorectal cancer (MCRC): Phase I results.
    Maiello, E
    Lopez, M
    Iaffaioli, RV
    Tambaro, R
    Paoletti, G
    Giuliani, F
    Colucci, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 296S - 296S
  • [22] Oral adjuvant chemotherapy using uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: Long-term survival results of the phase III UFT/LV study
    Hasegawa, Kiyoshi
    Saiura, Akio
    Takayama, Tadatoshi
    Miyagawa, Shinichi
    Yamamoto, Junji
    Bandai, Yasutsugu
    Teruya, Masanori
    Yoshimi, Fuyo
    Kawasaki, Seiji
    Koyama, Hiroto
    Oba, Masaru
    Takahashi, Michiro
    Yamashita, Suguru
    Mizunuma, Nobuyuki
    Matsuyama, Yutaka
    Watanabe, Toshiaki
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [23] Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: Joint United States and Japan study of UFT/LV
    Shirao, K
    Hoff, PM
    Ohtsu, A
    Loehrer, PJ
    Hyodo, L
    Wadler, S
    Wadleigh, RG
    O'Dwyer, PJ
    Muro, K
    Yamada, Y
    Boku, N
    Nagashima, F
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (17) : 3466 - 3474
  • [24] Phase I study of paclitaxel, UFT and leucovorin calcium in patients with metastatic solid tumors.
    Tkaczuk, KH
    Doyle, LA
    Tait, N
    Quinn, C
    Duckham, E
    Buadi, F
    Chen, T
    Edelman, M
    ANNALS OF ONCOLOGY, 2000, 11 : 137 - 137
  • [25] Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer
    Hoff, PM
    Janjan, N
    Saad, ED
    Skibber, J
    Crane, C
    Lassere, Y
    Cleary, KR
    Benner, S
    Randolph, J
    Abbruzzese, JL
    Pazdur, R
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3529 - 3534
  • [26] Phase I/II study of 24-hour infusion of irinotecan (CPT-11) in combination with sequential oral leucovorin (LV) and uracil/tegafur (UFT) for patients (PTS) with metastatic colorectal cancer (MCRC)
    Sadahiro, Sotaro
    Maeda, Yuji
    Suzuki, Toshiyuki
    Makuuchi, Hiroyasu
    Kamijo, Akemi
    Murayama, Chieko
    ANNALS OF ONCOLOGY, 2006, 17 : 117 - 117
  • [27] Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: A University of Chicago phase II consortium study
    Mani, S
    Kugler, JW
    Sciortino, DF
    Garcia, JC
    Ansari, RH
    Humerickhouse, R
    Michelassi, F
    Posner, MC
    Shulman, KL
    Schilsky, RL
    List, M
    Vokes, EE
    Benner, S
    ANNALS OF ONCOLOGY, 1998, 9 (09) : 1035 - 1037
  • [28] Phase II Study of Tegafur/Uracil and Leucovorin plus Bevacizumab for Elderly Patients with Advanced Colorectal Cancer
    Murata, Kohei
    Mizushima, Tsunekazu
    Tamagawa, Koji
    Matsuda, Chu
    Fukunaga, Mutsumi
    Hata, Taishi
    Nezu, Riichiro
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
    Cellier, Patrice
    Leduc, Bernard
    Martin, Laurent
    Vie, Brigitte
    Chevelle, Christian
    Vendrely, Veronique
    Salemkour, Augustin
    Carrie, Christian
    Calais, Gilles
    Burtin, Pascal
    Campion, Loic
    Boisdron-Celle, Michele
    Morel, Alain
    Berger, Virginie
    Gamelin, Erick
    BMC CANCER, 2011, 11
  • [30] Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
    Patrice Cellier
    Bernard Leduc
    Laurent Martin
    Brigitte Vié
    Christian Chevelle
    Véronique Vendrely
    Augustin Salemkour
    Christian Carrie
    Gilles Calais
    Pascal Burtin
    Loïc Campion
    Michèle Boisdron-Celle
    Alain Morel
    Virginie Berger
    Erick Gamelin
    BMC Cancer, 11
12345